AlphaOmega
Nazareth, IsraelFounded 1993
- Neuromodulation
- EEG and neural monitoring
- Neuroimaging
- Neuroscience research tools
AlphaOmega develops neuroscience and neurosurgery systems, software, and solutions for neurophysiology research and functional neurology. Its products support deep brain stimulation (DBS), brain mapping, and surgical navigation, with tools for researchers, clinicians, and patients.
- RaisedTotal raised
- $7M
- Investor
- 1
- Founded
- 1993
- Employees
- 101–250
reccy insights
Its funding history includes a $7 million Venture Round announced on Dec 11, 2018, with GIBF as lead investor; that is a historical financing milestone rather than a recent development. The company’s established focus is on combining hardware and software for clinical and research applications, including deep brain stimulation and neural recording. Several other dated leadership and company-news items associated with the Alpha Omega name concern U.S. government contracting and do not appear consistent with this company’s Israeli neuroscience identity, so they are not treated as company highlights.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
What makes AlphaOmega distinct
- 01Develops systems for neuroscience experiments involving humans, primates, and rodents.
- 02Focuses on making deep brain stimulation procedures simpler, more effective, and more affordable.
- 03Combines hardware and software for brain mapping and navigation, supporting awake and asleep procedures.
- 04Provides engineering and customer support for neuroscience and neurosurgery solutions.
- 05Supports clinical research and DBS procedures through a global team.
Technology & products6
- Neuro Omega
A software and hardware system for clinical microelectrode recording and advanced clinical research in neurophysiology.
- AlphaComm-A
A motorized commutator that tracks and compensates for rotations in tethers connected to freely moving animals, supporting neural recording and stimulation.
- AlphaComm-I
A motorized commutator compatible with Intan-based systems that prevents tether entanglement in freely moving animals during neural recording and stimulation.
+ 3 more: αCare SENS™, Clinical Research Platform, EPS (Electrode Positioning System)
Funding
- Venture RoundDec 2018$7MLed by GIBF
Similar companies
About AlphaOmega
- Products
- Neuro Omega, AlphaComm-A, AlphaComm-I, αCare SENS™, Clinical Research Platform, EPS (Electrode Positioning System)
- Leadership
- Anthony Olvera, CEOImad Younis, PresidentReem Younis, Owner & Co-FounderAjwad Akashi, COO
- Focus areas
- Neuroscience, neurosurgery, medical devices, deep brain stimulation, neurophysiology, clinical research, brain mapping
- Headquarters
- Nazareth, Israel
- Founded
- 1993
- Employees
- 101–250
- Patents granted
- 13